** Shares of Tylenol-maker Kenvue KVUE.N fall 6.8% to $22.07, the biggest decliner among S&P 500 .SPX constituents
** KVUE execs say at a Deutsche Bank conference that retailers have been de-stocking products in China and U.S. due to tariff-related uncertainty
** Co says the tariff environment created a lot of uncertainty for retailers, leading to immediate actions with shipments "definitely trailing consumption" in Q2
** Co expects a gross tariff impact of around $150 million for 2025, though they mentioned seeing "a slight positive on the China front" since their previous update - conf
* Kenvue expects Q2 to be "not materially different from Q1" - conf
** Including session moves, stock up 4.8% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。